DYN ▲ +4.3% - Dyne Therapeutics, Inc. $DYN - Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Dyne Therapeutics announced inducement grants to new employees under Nasdaq rules, a routine disclosure that typically signals recent hiring or retention of key staff. The stock rose 4.3% on the news, though the market reaction likely reflects broader positive sentiment around the company's growth trajectory rather than the grant announcement itself. 17-SEP-2026 04:06 PM ET